Synapse - Hematologic Malignancies, Division of

Results (13379)

A timelapse of patient and provider care perceptions and educational needs for CLL over three years of tailored educational interventions

Meeting Abstract

Ackbarali, T.; O'Brien, S.; Mato, A. R.; Davids, M. S.
Blood (2022)

Fulltext@MSK | Save

Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition

Meeting Abstract

Grilo, A. M.; Klaus, C.; McDonald, A.; Gollob, J.; Weiss, M.; O'Connor, O. A.; Salles, G.; Chaudhuri, J.; Lue, J. K.
Blood (2022)

Fulltext@MSK | Save

A phase 2/3, randomized, double blind, placebo-controlled, multicenter study of NKTR-255 vs placebo following CD-19 directed CAR-T therapy in patients with relapsed/refractory large B-cell lymphoma

Meeting Abstract

Perales, M. A.; Ahmed, S.; Dahiya, S.; Riedell, P. A.; McGuirk, J. P.; Oluwole, O. O.; Chaudhry, S. A.; Lee, Z.; Dai, S.; Dixit, N.; more...
Blood (2022)

Fulltext@MSK | Save

Single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: Final analysis of the DREAMM-2 trial

Meeting Abstract

Nooka, A. K.; Cohen, A.; Lee, H. C.; Badros, A. Z.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; Libby, E.; more...
Blood (2022)

Fulltext@MSK | Save

Assessing the burden of adverse events in a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia (CLL)

Meeting Abstract

Seymour, J. F.; Byrd, J. C.; Munir, T.; Ghia, P.; Kater, A. P.; Chanan-Khan, A.; Furman, R. R.; O'Brien, S.; Brown, J. R.; Mato, A. R.; more...
Blood (2022)

Fulltext@MSK | Save

Initial results of dose escalation of ISB 1342, a novel CD3xCD38 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Mohan, S. R.; Chase, C. C.; Berdeja, J. G.; Karlin, L.; Belhadj, K.; Perrot, A.; Moreau, P.; Touzeau, C.; Chalopin, T.; Lesokhin, A. M.; more...
Blood (2022)

Fulltext@MSK | Save

Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience

Meeting Abstract

Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
Blood (2022)

Fulltext@MSK | Save

Patterns of childbirth in women with myeloproliferative neoplasms

Meeting Abstract

Landtblom, A. R.; Andersson, T. M. L.; Johansson, A. L. V.; Lundberg, F. E.; Samuelsson, J.; Björkholm, M.; Hultcrantz, M.
Blood (2022)

Fulltext@MSK | Save

Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML

Meeting Abstract

Wheeler, E. C.; Martin, B.; Doyle, W.; Gorelov, R.; Donahue, M.; Jann, J. C.; Abdel-Wahab, O.; Taylor, J.; Seiler, M.; Buonamici, S.; more...
Blood (2022)

Fulltext@MSK | Save

Real world comparison of bruton tyrosine kinase inhibitors and venetoclax in patients diagnosed with chronic lymphocytic leukemia or small lymphocytic lymphoma

Meeting Abstract

Roeker, L. E.; Han, Y.; Ryan, K. J.; Teschemaker, A.; Mato, A. R.
Blood (2022)

Fulltext@MSK | Save